Stock Events

Stock Events

Charles River Laboratories International 

$312.47
101
-$12.45-3.83%Friday 07:13

Statistics

Day High
312.48
Day Low
312
52W High
376.1
52W Low
148.54
Volume
29
Avg. Volume
-
Mkt Cap
14.92B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 1996
$0.10
Dec 1996
$0.10
Nov 1996
$0.10
Nov 1996
$0.10
Nov 1996
$0.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Nov 4Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
1.94
2.33
2.71
3.09
Expected EPS
2.972988
Actual EPS
3.09

Financials

-3.59%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.02BRevenue
-144.34MNet Income

Analyst Ratings

$330.58Average Price Target
The highest estimate is ⁦400.00⁩.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
17%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRL.BOATS. It's not an investment recommendation.
Microsoft
34
MSFT
Apple
28
AAPL
Amazon
27
AMZN
NVIDIA
27
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap44.06B
IQVIA provides similar contract research services, including preclinical and clinical trials, making it a direct competitor.
Icon Energy
ICON
Mkt Cap3.73M
ICON plc offers clinical research services, making it a competitor in the pharmaceutical and biotechnology development sector.
Wuxi AppTec.
WUXAY
Mkt Cap60.27B
WuXi AppTec provides a broad range of R&D and manufacturing services, competing in pharmaceutical, biotech, and medical device R&D.
Medpace
MEDP
Mkt Cap18.24B
Medpace Holdings, Inc. specializes in clinical research services, directly competing with CRL in the CRO market.
Illumina
ILMN
Mkt Cap35.63B
Illumina, Inc. provides genomics and sequencing services, indirectly competing by offering critical technologies for biopharmaceutical research.

About

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Show More
CEO
ISIN
US1598641074

Listings

LSE
GB
0ADA.LSE
STU
DE
RV6.STU
MU
DE
RV6.MU
F
DE
RV6.F

0 Comments

Share your thoughts

FAQs

What is Charles River Laboratories International stock price today?▼
The current price of CRL.BOATS is $312.47 USD — it has decreased by -3.83% in the past 24 hours. Watch Charles River Laboratories International stock price performance more closely on the chart.
What is Charles River Laboratories International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Charles River Laboratories International stocks are traded under the ticker CRL.BOATS.
What is Charles River Laboratories International market cap?▼
Today Charles River Laboratories International has the market capitalization of 14.92B
When is the next Charles River Laboratories International earnings date?▼
Charles River Laboratories International is going to release the next earnings report on February 24, 2027.
What were Charles River Laboratories International earnings last quarter?▼
CRL.BOATS earnings for the last quarter are 3.09 USD per share, whereas the estimation was 2.97 USD resulting in a +3.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Charles River Laboratories International revenue for the last year?▼
Charles River Laboratories International revenue for the last year amounts to 4.02B USD.
What is Charles River Laboratories International net income for the last year?▼
CRL.BOATS net income for the last year is -144.34M USD.
Does Charles River Laboratories International pay dividends?▼
Yes, CRL.BOATS dividends are paid monthly. The last dividend per share was 0.1 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Charles River Laboratories International located?▼
Charles River Laboratories International operates in the Other sector.
When did Charles River Laboratories International complete a stock split?▼
Charles River Laboratories International has not had any recent stock splits.